A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Solid Tumors
Clinical trial NCT06801470 · RECRUITING
Trial details
- NCT number
- NCT06801470
- Sponsor
- CD (Suzhou) Biopharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2028-01-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.